Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGX267 for Xerostomia in Sjögren's Syndrome
NCT00637793Phase 2Completed
- Sponsor
- TorreyPines Therapeutics
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NGX267 in xerostomia, sponsored by TorreyPines Therapeutics. Started Feb 2008; status: completed.
02
Drugs
NGX267
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT00637793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637793.